• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.1α型代谢型谷氨酸受体刺激的[35S]-GTPγS结合的药理学特性
Br J Pharmacol. 1997 Jul;121(6):1203-9. doi: 10.1038/sj.bjp.0701238.
2
Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.激动剂对克隆的人κ阿片受体的激活增强了[35S]GTPγS与膜的结合:配体效力和效能的测定。
J Pharmacol Exp Ther. 1997 Aug;282(2):676-84.
3
Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.用鸟嘌呤核苷酸-5'-O-(3-[(35)S]硫代)三磷酸结合测定法评估大鼠大脑皮质代谢型谷氨酸受体与 G 蛋白的功能偶联。
Basic Clin Pharmacol Toxicol. 2011 Sep;109(3):175-85. doi: 10.1111/j.1742-7843.2011.00705.x. Epub 2011 May 5.
4
Enhanced type 1alpha metabotropic glutamate receptor-stimulated phosphoinositide signaling after pertussis toxin treatment.百日咳毒素处理后1α型代谢型谷氨酸受体刺激的磷酸肌醇信号增强。
Mol Pharmacol. 1997 Sep;52(3):406-14. doi: 10.1124/mol.52.3.406.
5
5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.5-羟色胺刺激的[35S]鸟苷-5'-O-(3-硫代)三磷酸结合作为大鼠纹状体膜中与5-羟色胺1B受体偶联的G蛋白功能激活的一种检测方法。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):335-45. doi: 10.1007/s00210-006-0041-x. Epub 2006 Feb 21.
6
Pharmacological characterisation of melatonin mt1 receptor-mediated stimulation of [35S]-GTPgammaS binding.褪黑素mt1受体介导的[35S]-GTPγS结合刺激的药理学特性
Biochem Pharmacol. 1998 Nov 1;56(9):1167-74. doi: 10.1016/s0006-2952(98)00254-8.
7
[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.以[35S]鸟苷-5'-O-(3-硫代)三磷酸结合作为衡量人重组多巴胺D4.4受体效能的指标:抗帕金森病药和抗精神病药的作用
J Pharmacol Exp Ther. 1997 Jul;282(1):181-91.
8
G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.高表达中国仓鼠卵巢细胞中人多巴胺D3受体介导的G蛋白激活:一项[35S]硫代三磷酸鸟苷结合及抗体研究。
Mol Pharmacol. 1999 Mar;55(3):564-74.
9
The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.公认的“沉默”5-羟色胺(5-HT)1A受体拮抗剂WAY 100635,对克隆的人5-HT1A受体具有反向激动剂特性。
Eur J Pharmacol. 2000 Jul 28;401(1):9-15. doi: 10.1016/s0014-2999(00)00410-6.
10
Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.通过鸟苷5'-γ-硫代三磷酸-35S结合测定多巴胺D3受体的激动剂和反向激动剂活性。
J Pharmacol Exp Ther. 1998 Apr;285(1):119-26.

引用本文的文献

1
Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.内源性阿片类镇痛药的裁决者:中枢神经系统雌激素和谷氨酸能系统的作用。
Transl Res. 2021 Aug;234:31-42. doi: 10.1016/j.trsl.2021.02.002. Epub 2021 Feb 7.
2
Harnessing endogenous opioids for pain relief: Fantasy vs reality.利用内源性阿片类物质缓解疼痛:幻想与现实
J Opioid Manag. 2019 Jan/Feb;16(1):67-72. doi: 10.5055/jom.2020.0552.
3
Exploiting endogenous opioids: Lessons learned from endomorphin 2 in the female rat.内源性阿片肽的开发:内吗啡肽 2 在雌性大鼠中获得的启示。
Peptides. 2019 Feb;112:133-138. doi: 10.1016/j.peptides.2018.12.002. Epub 2018 Dec 14.
4
Recent advances in the medicinal chemistry of group II and group III mGlu receptors.II 型和 III 型代谢型谷氨酸受体药物化学的最新进展。
Medchemcomm. 2017 Jan 13;8(3):501-515. doi: 10.1039/c6md00612d. eCollection 2017 Mar 1.
5
Plasticity of Signaling by Spinal Estrogen Receptor α, κ-Opioid Receptor, and Metabotropic Glutamate Receptors over the Rat Reproductive Cycle Regulates Spinal Endomorphin 2 Antinociception: Relevance of Endogenous-Biased Agonism.大鼠生殖周期中脊髓雌激素受体α、κ-阿片受体和代谢型谷氨酸受体信号转导的可塑性调节脊髓内吗啡肽2的抗伤害感受:内源性偏向激动作用的相关性
J Neurosci. 2017 Nov 15;37(46):11181-11191. doi: 10.1523/JNEUROSCI.1927-17.2017. Epub 2017 Oct 12.
6
Molecular Basis for Modulation of Metabotropic Glutamate Receptors and Their Drug Actions by Extracellular Ca.细胞外钙对代谢型谷氨酸受体的调节及其药物作用的分子基础
Int J Mol Sci. 2017 Mar 21;18(3):672. doi: 10.3390/ijms18030672.
7
Simulation of postsynaptic glutamate receptors reveals critical features of glutamatergic transmission.模拟突触后谷氨酸受体揭示了谷氨酸能传递的关键特征。
PLoS One. 2011;6(12):e28380. doi: 10.1371/journal.pone.0028380. Epub 2011 Dec 15.
8
Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor.由人类疱疹病毒8 g蛋白偶联受体C末端的病毒趋化因子受体保守区域所确定的Gα蛋白选择性决定因素。
J Virol. 2004 Mar;78(5):2460-71. doi: 10.1128/jvi.78.5.2460-2471.2004.
9
Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.I 型代谢型谷氨酸受体的结构、信号传导及调节特性:典型的C类G蛋白偶联受体
Biochem J. 2001 Nov 1;359(Pt 3):465-84. doi: 10.1042/0264-6021:3590465.
10
Effects of varying the expression level of recombinant human mGlu1alpha receptors on the pharmacological properties of agonists and antagonists.改变重组人代谢型谷氨酸受体1α(mGlu1α)表达水平对激动剂和拮抗剂药理学特性的影响。
Br J Pharmacol. 1999 Feb;126(4):873-82. doi: 10.1038/sj.bjp.0702359.

1α型代谢型谷氨酸受体刺激的[35S]-GTPγS结合的药理学特性

Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.

作者信息

Akam E C, Carruthers A M, Nahorski S R, Challiss R A

机构信息

Department of Cell Physiology and Pharmacology, University of Leicester.

出版信息

Br J Pharmacol. 1997 Jul;121(6):1203-9. doi: 10.1038/sj.bjp.0701238.

DOI:10.1038/sj.bjp.0701238
PMID:9249258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1564797/
Abstract
  1. The activation of G proteins by type 1alpha metabotropic glutamate receptors (mGluRs) in membranes from recombinant baby hamster kidney cells expressing the cloned rat mGluR1alpha receptor has been studied by use of a [35S]-guanosine 5'-[gamma-thio]triphosphate ([35S]-GTPgammaS) binding assay. 2. L-Glutamate increased the rate of [35S]-GTPgammaS binding in a concentration-dependent manner (-logEC50 (M) 5.25 +/- 0.07), with an optimal (62.4 +/- 1.6%) increase over basal binding being observed following 60 min incubation at 30 degrees C with 70 pM [35S]-GTPgammaS, 1 microM GDP, 10 mM MgCl2, 100 mM NaCl and 100 microg membrane protein ml(-1). The L-glutamate (100 microM)-stimulated increase in [35S]-GTPgammaS binding was totally prevented in the presence of the group I mGluR antagonist (S)-4-carboxy-3-hydroxyphenylglycine (300 microM). 3. Quantitative analysis of the affinity and number of G proteins activated by a maximally effective concentration of L-glutamate revealed an equilibrium dissociation constant (K(D)) for [35S]-GTPgammaS binding of 0.76 +/- 0.20 nM and a maximal number of GTPgammaS-liganded G proteins (Bmax) of 361 +/- 30 fmol mg(-1) protein. 4. Metabotropic glutamate receptor agonists, quisqualate (-logEC50 (M) 6.74 +/- 0.06), 1S,3R-ACPD (4.64 +/- 0.08) and (S)-3,5-dihydroxyphenylglycine (5.16 +/- 0.23) also increased [35S]-GTPgammaS binding in a concentration-dependent manner, with the latter two agents behaving as partial agonists. 5. (+)-alpha-Methylcarboxyphenylglycine (300 microM) caused a parallel rightward shift of the L-glutamate concentration-effect curve for [35S]-GTPgammaS binding, allowing an antagonist equilibrium dissociation constant (K(D)) of 34.0 +/- 7.8 microM to be calculated for this mGluR antagonist. 6. Pretreatment of BHK-mGluR1alpha cells with a concentration of pertussis toxin (PTX) shown to be maximally effective (100 ng ml(-1), 24 h) before membrane preparation resulted in a marked decrease in agonist-stimulated [35S]-GTPgammaS binding (by 66.0 +/- 0.9%), and an altered concentration-effect relationship for agonist-stimulated [35S]-GTPgammaS binding by the residual PTX-insensitive G-protein population. 7. The modulation of [35S]-GTPgammaS binding by agonists and antagonists in membranes from recombinant cells provides an excellent system in which to study mGluR interactions with PTX-sensitive and -insensitive G proteins.
摘要
  1. 利用[35S]-鸟苷5'-[γ-硫代]三磷酸([35S]-GTPγS)结合试验,研究了表达克隆大鼠mGluR1α受体的重组幼仓鼠肾细胞膜中1α型代谢型谷氨酸受体(mGluRs)对G蛋白的激活作用。2. L-谷氨酸以浓度依赖方式增加[35S]-GTPγS结合速率(-logEC50(M)5.25±0.07),在30℃下用70 pM [35S]-GTPγS、1 μM GDP、10 mM MgCl2、100 mM NaCl和100 μg膜蛋白ml-1孵育60分钟后,与基础结合相比,观察到最佳增加(62.4±1.6%)。在I组mGluR拮抗剂(S)-4-羧基-3-羟基苯甘氨酸(300 μM)存在下,L-谷氨酸(100 μM)刺激的[35S]-GTPγS结合增加完全被阻断。3. 对最大有效浓度L-谷氨酸激活的G蛋白的亲和力和数量进行定量分析,得出[35S]-GTPγS结合的平衡解离常数(K(D))为0.76±0.20 nM,GTPγS结合的G蛋白最大数量(Bmax)为361±30 fmol mg-1蛋白。4. 代谢型谷氨酸受体激动剂喹啉酸(-logEC50(M)6.74±0.06)、1S,3R-ACPD(4.64±0.08)和(S)-3,5-二羟基苯甘氨酸(5.16±0.23)也以浓度依赖方式增加[35S]-GTPγS结合,后两种试剂表现为部分激动剂。5. (+)-α-甲基羧基苯甘氨酸(300 μM)使[35S]-GTPγS结合的L-谷氨酸浓度-效应曲线平行右移,从而计算出该mGluR拮抗剂的拮抗剂平衡解离常数(K(D))为34.0±7.8 μM。6. 在制备膜之前,用显示为最大有效浓度(100 ng ml-1,24小时)的百日咳毒素(PTX)预处理BHK-mGluR1α细胞,导致激动剂刺激的[35S]-GTPγS结合显著降低(降低66.0±0.9%),并且残余的对PTX不敏感的G蛋白群体对激动剂刺激的[35S]-GTPγS结合的浓度-效应关系发生改变。7. 激动剂和拮抗剂对重组细胞膜中[35S]-GTPγS结合的调节提供了一个极好的系统,用于研究mGluR与对PTX敏感和不敏感的G蛋白的相互作用。